MEHDI SOLEYMANI-GOLOUJEH, Ph.D.
Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]
Jeffrey M. Skredenske
Accomplished expert in biologics (upstream and downstream) and bioconjugation with deep experience in process development, manufacturing, and process validation. Demonstrated success leading cross-functional teams and managing strategic CDMO partnerships to advance monoclonal antibody and antibody-drug conjugate programs through early- and late-phase clinical trials and IND and BLA preparation and submission. Strong background in high-impact project […]